The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20261034: KKR Pegasus Aggregator L.P.; Sunopta Inc.
20261047: Coral Acquisition, Inc.; Thompson Street Capital Partners V, L.P.
20261054: Softbank Group Corp.; SL Energy I Topco, LLC
20261065: Arkoma Drilling, L.P.; Quantum Capital Solutions II, LP
20261081: BayPine Regal Co-Invest, LP; Aquiline Financial Services Continuation Fund L.P.
Dr. Donald McCrosky, In the Matter of
Agency Information Collection Activities; Proposed Collection; Comment Request; Extension (Warranty Rule)
OkCupid/Match
The FTC reached a settlement with OkCupid and its affiliate Match Group Americas over allegations OkCupid deceived users of its dating app by sharing their personal information, including photos and location information, with an unrelated third party, contrary to OkCupid’s privacy promises.
20251851: Gray Media, Inc.; Byron Allen Folks
Agency Information Collection Activities; Proposed Collection; Comment Request; Extension (Affiliate Marketing Rule)
Craig Lewis, In the Matter of
Philip Serpe, In the Matter of
Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin)
The FTC filed a lawsuit against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs.
On February 4, 2026, the Federal Trade Commission secured a landmark settlement with Express Scripts, Inc., and its affiliated entities (collectively “ESI”). The settlement requires ESI to adopt fundamental changes to its business practices that increase transparency, are expected to drive down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, bring millions of dollars in new revenue to community pharmacies each year, and advance the Trump Administration’s key healthcare priorities.